SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-065383
Filing Date
2024-05-28
Accepted
2024-05-28 17:24:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 424b3-dnth-8k-annual_mee.htm 424B3 235601
2 GRAPHIC img236146366_0.jpg GRAPHIC 173401
  Complete submission text file 0000950170-24-065383.txt   469455
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274863 | Film No.: 24993117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)